Inventor · disambiguated record
Helene Le Buanec
Also filed as: LE BUANEC HELENE · LE BUANEC HÉLÈNE
7 granted patents·6 pending applications·19 citations·filing 2001–2021
76Inventor score
Files withINST NAT SANTE RECH MED5NEOVACS3BIZZINI BERNARD1INSERM INSTITUT NAT DE LA SANTE ET DE LA RECHERCH MEDICALE1ZAGURY JEAN-FRANCOIS1
Top patents by PatentIndex Score
13 records- 0184US7314629B2Non-immunosuppressive immunogenic or vaccine composition comprising a mutated E7 protein of the HPV-16 virusNEOVACS·Filed 2003·Granted Jan 1, 2008·15 cites·24 claims
- 0272US7887811B2Method for preparing a stable immunogenic product comprising antigenic heterocomplexes of TNFα and a carrier proteinNEOVACS·Filed 2006·Granted Feb 15, 2011·2 cites·16 claims
- 0366US8101165B2Use of immunogens to treat or prevent, in malignant tumors, the immune or vascular disorders induced by extracellular factorsZAGURY JEAN FRANCOIS·Filed 2007·Granted Jan 24, 2012·0 cites·4 claims
- 0458US8679483B2High-yield method for the production of human antibodies blocking the biological activity of a human cytokineBIZZINI BERNARD·Filed 2004·Granted Mar 25, 2014·2 cites·20 claims
- 0554US2023323299A1Population of treg cells functionally committed to exert a regulatory activity and their use for adoptive therapyINSERM INSTITUT NAT DE LA SANTE ET DE LA RECHERCH MEDICALE·Filed 2021·Application pending·0 cites
- 0653US8372388B2Method for preparing a stable TNF-α vaccineNEOVACS·Filed 2005·Granted Feb 12, 2013·0 cites·20 claims
- 0751US2004028647A1Vaccines against cytokines and growth factors derived from malignant tumoursFiled 2001·Application pending·0 cites
- 0851US2022119766A1Ex vivo generation of gamma delta foxp3+ regulatory t cells and therapeutic uses thereofINST NAT SANTE RECH MED·Filed 2021·Application pending·0 cites
- 0950US2022018835A1Use of cd26 and cd39 as new phenotypic markers for assessing maturation of foxp3+ t cells and uses thereof for diagnostic purposesINST NAT SANTE RECH MED·Filed 2019·Application pending·0 cites
- 1048US2004185058A1Composite superimmunogen for bi-functional vaccine use for the treatment of illnesses associated with a stromal tissue disorderFiled 2002·Application pending·0 cites
- 1141US11365392B2Ex vivo generation of MHCII restricted CD4+ FOXP3+ regulatory T cells and therapeutic uses thereofINST NAT SANTE RECH MED·Filed 2017·Granted Jun 21, 2022·0 cites·3 claims
- 1240US11198851B2Ex vivo generation of γδ Foxp3+ regulatory T cells and therapeutic uses thereofINST NAT SANTE RECH MED·Filed 2017·Granted Dec 14, 2021·0 cites·4 claims
- 1334US2019167791A1Immunotherapeutic uses of ex vivo generated foxp3+ regulatory t cellsINST NAT SANTE RECH MED·Filed 2017·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →